Bayban’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Bayban's NVS Position: Q3 2026 in Review
Bayban held its Novartis (NVS) position steady in Q3 2026 at 229 shares worth $32.6K. The position accounts for 0.02% of the portfolio, ranked #292.
Bayban first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $35.9K in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Bayban held 229 shares of Novartis worth $32.6K as of Q3 2026.
- Bayban left its Novartis share count unchanged in Q3 2026.
- Novartis made up 0.02% of Bayban's portfolio in Q3 2026, its #292 holding.
- Bayban first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
- Bayban's Novartis position peaked at $35.9K in Q2 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.